MilliporeSigma
  • Effects of L-arginine, mirabegron, and oxybutynin on the primary bladder afferent nerve activities synchronized with reflexic, rhythmic bladder contractions in the rat.

Effects of L-arginine, mirabegron, and oxybutynin on the primary bladder afferent nerve activities synchronized with reflexic, rhythmic bladder contractions in the rat.

Neurourology and urodynamics (2014-02-18)
Naoki Aizawa, Yukio Homma, Yasuhiko Igawa
ABSTRACT

We measured single-unit mechanosensitive afferent activities (SAAs) during reflexic, rhythmic bladder contractions (RBCs), and examined whether L-arginine, an NO substrate, and mirabegron, a β3-adrenoceptor agonist, and oxybutynin, an antimuscarinic agent, can affect the SAAs in such condition. Twenty-nine female Sprague-Dawley rats were anesthetized. SAA was identified by electro-stimulation of the left pelvic nerve and by bladder distension, and was divided into Aδ- or C-fibers by conduction velocity. To produce the RBCs, right L6 dorsal roots were kept intact. Under an isovolumetric condition, vehicle and L-arginine (300 mg/kg) or mirabegron (1 mg/kg) or oxybutynin (1 mg/kg) were administered intravenously. All of the Aδ- (n = 26) and C-fibers (n = 29) capable of responding to bladder distention were also responsive to bladder contractions during RBCs. The amplitude and duration of RBCs significantly decreased after mirabegron- and oxybutynin-administrations, but not after L-arginine-administration. The interval of RBC was significantly elongated after L-arginine- and mirabegron-administrations. Regarding the SAAs, the peaks of firing rate (FR) during RBCs and FR during the non-contractile phase were decreased after L-arginine-administration, which were more remarkable for Aδ-fibers than C-fibers. Similar results were observed after mirabegron-administration only for Aδ-fibers. After oxybutynin-administration, the peak of FR of both fiber-SAAs significantly decreased, but the change was not significant when the value was normalized by the amplitude of RBCs. The present results indicate that mechanosensitive Aδ- and C-fibers were also responsive to bladder contractions, and that NO production and β3-adrenoceptor stimulation can inhibit SAAs mainly of Aδ-fibers synchronized with RBCs.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Acetanilide, 99%
Sigma-Aldrich
2-Aminothiazole, 97%
Sigma-Aldrich
Acetanilide, purified by sublimation, ≥99.9%
Sigma-Aldrich
Acetanilide, zone-refined, purified by sublimation, ≥99.95%
Sigma-Aldrich
Acetanilide, puriss. p.a., ≥99.5% (CHN)
Sigma-Aldrich
5-(N,N-Dimethyl)amiloride hydrochloride
Sigma-Aldrich
L-Arginine, reagent grade, ≥98%
Sigma-Aldrich
N,N-Dimethylacetamide-d9, 99 atom % D
Sigma-Aldrich
L-Arginine, 99%, FCC, FG
Sigma-Aldrich
N,N-Dimethylacetamide, ReagentPlus®, ≥99%
Sigma-Aldrich
N,N-Dimethylacetamide, anhydrous, 99.8%
Sigma-Aldrich
L-Arginine, BioUltra, ≥99.5% (NT)
USP
Acetanilide Melting Point Standard, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
N,N-Dimethylacetamide, suitable for peptide synthesis, ≥99.8% (GC)
Supelco
N,N-Dimethylacetamide, analytical standard
Supelco
Acetanilide melting point standard, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
L-Arginine, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
N,N-Dimethylacetamide, spectrophotometric grade, ≥99%
Sigma-Aldrich
N,N-Dimethylacetamide, suitable for HPLC, ≥99.9%
Supelco
Acetaminophen Related Compound D, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
N,N-Dimethylacetamide, ReagentPlus®, 99%
Sigma-Aldrich
N,N-Dimethylacetamide, puriss. p.a., ≥99.5% (GC)
SAFC
N,N-Dimethylacetamide
SAFC
L-Arginine
Sigma-Aldrich
L-Arginine, from non-animal source, meets EP, USP testing specifications, suitable for cell culture, 98.5-101.0%